CS
Catherine Schulte Baird Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
28
Avg Return
Past Year
Past Year
7.9%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
67.9%
Neutral
32.1%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mega Cap
Over $200B
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Diagnostics & Research
Drug Manufacturers - General
Medical Instruments & Supplies
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Outperform
Maintained
| $165 |
12%
upside
| 4 | +3.8% |
0
%
| 25 Nov ‘25 1 month ago |
|
|
|
Outperform
Maintained
| $88 |
13%
downside
| 2 | +47% |
0
%
| 4 Nov ‘25 2 months ago |
|
|
|
Outperform
Maintained
| $17 |
41%
upside
| 4 | +1% |
0
%
| 24 Oct ‘25 2 months ago |
|
|
|
Neutral
Maintained
| $1,230 |
16%
downside
| 4 | – |
–
| 4 Aug ‘25 5 months ago |
|
|
|
Outperform
Maintained
| $567 |
8%
downside
| 3 | +14% |
0
%
| 24 Jul ‘25 5 months ago |
|
|
|
Outperform
Maintained
| $229 |
3%
downside
| 5 | +1.9% |
0
%
| 23 Jul ‘25 5 months ago |
|
|
|
Neutral
Maintained
| $2 |
48%
downside
| 2 | -60% |
–
| 13 May ‘25 8 months ago |
|
|
|
Neutral
Maintained
| $43 |
10%
downside
| 2 | – |
–
| 21 Apr ‘25 8 months ago |
|
|
|
Neutral
Downgraded
| $68 |
5%
upside
| 2 | -13% |
0
%
| 19 Feb ‘25 10 months ago |
|